Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Masahiro Uno"'
Autor:
Seiichi Kato, Manabu Takai, Koji Iinuma, Shota Fujimoto, Masahiro Nakano, Takashi Ishida, Masahiro Uno, Masayoshi Tamaki, Mitsuhiro Taniguchi, Hisao Komeda, Yoshito Takahashi, Takuya Koie
Publikováno v:
The Scientific World Journal, Vol 2021 (2021)
Background. Docetaxel (DOC) was the first regimen that increased the survival and became the standard-of-care in patients with metastatic castration-resistant prostate cancer (mCRPC). However, it is unclear whether switching to second-line chemothera
Externí odkaz:
https://doaj.org/article/955ba04ad759460bb378a81a0b2ee11f
Autor:
Kota Kawase, Torai Enomoto, Makoto Kawase, Manabu Takai, Daiki Kato, Shota Fujimoto, Koji Iinuma, Keita Nakane, Seiichi Kato, Noriyasu Hagiwara, Masahiro Uno, Takuya Koie
Publikováno v:
Medicina, Vol 58, Iss 4, p 485 (2022)
Background and objectives: This study aimed to evaluate the association between warm ischemic time (WIT) and postoperative renal function using Trifecta achievement in patients with renal cell carcinoma (RCC) who underwent robotic (RAPN) or laparosco
Externí odkaz:
https://doaj.org/article/701c71b214f04465a470ded4ffed588d
Autor:
Junichi Takekawa, Hitoshi Mikada, Shibo Xu, Masahiro Uno, Shiori Kamei, Kinzo Kishida, Daiji Azuma, Masafumi Aoyanagi, Naoto Tanaka, Hiroki Ichikawa
Publikováno v:
The Leading Edge. 41:338-346
We present a novel type of multicomponent sensor prototype that uses distributed acoustic sensing (DAS) technology. A prototype of the new sensor has three individual parts consisting of optical fiber wound around a polyvinyl chloride frame. We deplo
Autor:
Tomoko Matsuoka, Karen Takashima, Kengo Ohashi, Yasutaka Shinoda, Masahiro Uno, Yoshiaki Ikeda, Tomoaki Yoshimura
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:639-646
Autor:
Koji Iinuma, Shota Fujimoto, Seiichi Kato, Takuya Koie, Hisao Komeda, Mitsuhiro Taniguchi, Masahiro Nakano, Masahiro Uno, Manabu Takai, Takashi Ishida, Yoshito Takahashi, Masayoshi Tamaki
Publikováno v:
The Scientific World Journal, Vol 2021 (2021)
Background. Docetaxel (DOC) was the first regimen that increased the survival and became the standard-of-care in patients with metastatic castration-resistant prostate cancer (mCRPC). However, it is unclear whether switching to second-line chemothera
Publikováno v:
Kampo Medicine. 71:30-35
Autor:
Junichi Takekawa, Hitoshi Mikada, Shibo Xu, Masahiro Uno, Pairan Lin, Yusuke Watanabe, Ziyang Zhou, Ryo Masumura, Iktae Jang, Rundong Pan, Kosuke Kayama, Toshiki Matsuo, Ayane Ishizuki, Shiori Kamei, Kinzo Kishida, Daiji Azuma, Masafumi Aoyanagi, Naoto Tanaka, Hiroki Ichikawa
Publikováno v:
Sixth International Conference on Engineering Geophysics, Virtual, 25–28 October 2021.
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(10)
A 53-year-old woman had left pyonephrosis and bladder stone. A double-J ureteral stent was placed for left ureterostenosis and she was lost to followup. Five years later, she had back pain. Computed tomography revealed left hydronephrosis, pyonephros
Autor:
Makoto, Kawase, Shinichi, Takeuchi, Takashi, Ishida, Seiichi, Kato, Masahiro, Uno, Kei, Kurokawa, Toyonori, Tsuzuki
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(8)
A 56-year-old man visited a clinic with the chief complaint of frequent micturition and residual sensation of urine. He was referred to our hospital for close examination. Cystoscopy showed a tumor protruding toward the bladder neck from the prostate
Autor:
Koji Iinuma, Shota Fujimoto, Mitsuhiro Taniguchi, Masahiro Nakano, Takashi Ishida, Takuya Koie, Hisao Komeda, Manabu Takai, Seiichi Kato, Masahiro Uno, Yoshito Takahashi, Masayoshi Tamaki
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 17(3)
AIM To date, the optimal sequencing of life-prolonging therapies for patients with metastatic castration-resistant prostate cancer (mCRPC) remains unclear owing to a lack of prospective trials. This study aimed to evaluate the efficacy and safety of